Related Experiment Video

Updated: May 27, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.1K

TPC2 in drug development: Emerging target for cancer, viral infections, cardiovascular diseases, and neurological

Abeer F Alharbi1, John Parrington2

  • 1Pharmaceutical Sciences Department, College of Pharmacy, King Saud Bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Pharmacology, University of Oxford, Oxford, UK.

Pharmacological Research
|February 20, 2025
PubMed

Insights

Lysosomal TPC2 channels regulate calcium signaling and are linked to diseases like cancer and neurodegeneration. Developing specific TPC2 therapies requires understanding its complex interactions and mechanisms.

Area of Science:

  • Molecular biology
  • Cellular physiology
  • Pharmacology

Background:

  • Lysosomal two-pore channel 2 (TPC2) is crucial for intracellular calcium (Ca2+) signaling.
  • TPC2 dysfunction is implicated in inflammatory, cardiovascular, neurodegenerative diseases, cancer, and viral infections.
  • Despite therapeutic potential, TPC2 drug development faces challenges in specificity and understanding channel crosstalk.

Purpose of the Study:

  • To review recent advancements in TPC2 structural analysis and modulator development.
  • To highlight potential TPC2-based therapies for cancer, inflammation, and neurological disorders.
  • To emphasize the need for further research into targeted TPC2 modulators and molecular mechanisms.

Main Methods:

  • Review of recent scientific literature on TPC2 structure, function, and disease association.
  • Analysis of TPC2 agonists and inhibitors.
  • Discussion of TPC2's role in various pathological conditions.

Main Results:

  • Structural TPC2 analysis and modulator development have advanced understanding of its disease mechanisms.
  • TPC2 plays a significant role in cancer, inflammation, and neurological disorders.
  • Challenges remain in achieving target specificity and understanding TPC2's interactions with other calcium channels.

Conclusions:

  • Targeted TPC2 modulators offer therapeutic promise for several diseases.
  • Further research is essential to overcome specificity challenges and fully elucidate TPC2's molecular mechanisms.
  • Advancing TPC2-based therapies requires a deeper understanding of its complex role in cellular signaling.
Keywords:
CancerCardiovascular diseasesNeurological disordersTPC2Viral infections

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

2.8K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K